Other

Dataset Information

0

Inosine suppresses liver A-to-I RNA editing to promote cancer-associated cachexia in a riboswitch-like manner.


ABSTRACT: Cancer-associated cachexia (CAC) is a devastating syndrome and a major cause of morbidity and mortality in advanced cancer patients while liver is emerging as a key organ during CAC progression1. However, how tumor dysregulates liver function to promote CAC remains largely unknown. Here, we employ NMR spectrometry to detect that the elevation of 13C-inosine availability, attributed to the tumor-induced cytosolic 5'-nucleotidase II (NT5C2) protein accumulation, decreases the abundance of adenosine deaminase act on RNA 1 p150 isoform in a riboswitch-like manner. Intriguingly, reduced liver A-I mRNA editome enhances the stability of Cathepsin L mRNA to aggravate liver autophagy, triggering the secretion of serum amyloid A1, while CTSL-/- mice fail to develop cachectic phenotype upon inosine treatment. Strikingly, NT5C2 inhibitor CRCD2, a frontline leukemia treatment drug, greatly attenuates CAC progression. Conclusively, our finding reveals that inosine-mediated liver A-to-I mRNA editome alteration promotes CAC progression in a riboswitch-like manner, shedding light on the clinical applications for early CAC diagnosis and intervention.

ORGANISM(S): Mus musculus

PROVIDER: GSE262917 | GEO | 2026/04/21

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2026-04-21 | GSE262782 | GEO
2020-11-16 | GSE161499 | GEO
2022-03-23 | GSE182552 | GEO
| PRJNA1093377 | ENA
| PRJNA1094904 | ENA
2021-02-18 | PXD022677 | Pride
2021-08-10 | PXD020619 | Pride
2026-02-16 | GSE293990 | GEO
| PRJNA756782 | ENA
2014-08-22 | GSE60363 | GEO